First human trial for device that could prevent deadly aneurysm ruptures
NCT ID NCT05133492
Summary
This study is testing a new medical device called the Nectero EAST System for people with abdominal aortic aneurysms. The device aims to stabilize the weakened artery wall to prevent dangerous expansion or rupture. Researchers will follow 46 patients for up to 3 years to check if the treatment is safe and if it can stop the aneurysm from growing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Auckland City Hospital
Auckland, New Zealand
-
Pablo Tabon Uribe Hospital
Medellín, Antioquia, Colombia
-
Pauls Stradins Clinical University Hospital
Riga, Latvia
-
Prince of Wales Private Hospital
Randwick, New South Wales, 2031, Australia
-
Queen Mary Hospital
Hong Kong, Southern District, China
Conditions
Explore the condition pages connected to this study.